HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Armel Stockis Selected Research

Levetiracetam (Keppra)

8/2015Pharmacokinetics, Safety and Bioequivalence of Levetiracetam Intravenous Infusion and Oral Tablets in Healthy Chinese Subjects.
11/2014Levetiracetam pharmacokinetics in Japanese subjects with renal impairment.
11/2013Prospective Open-Label, Single-Arm, Multicenter, Safety, Tolerability, and Pharmacokinetic Studies of Intravenous Levetiracetam in Children With Epilepsy.
9/2010Assessment of levetiracetam bioavailability from targeted sites in the human intestine using remotely activated capsules and gamma scintigraphy: Open-label, single-dose, randomized, four-way crossover study in healthy male volunteers.
7/2009Clinical pharmacology of levetiracetam for the treatment of epilepsy.
1/2008Retrospective population pharmacokinetic analysis of levetiracetam in children and adolescents with epilepsy: dosing recommendations.
11/2007Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy.
6/2007Pharmacokinetics of levetiracetam in infants and young children with epilepsy.
4/2007Prospective assessment of levetiracetam pharmacokinetics during dose escalation in 4- to 12-year-old children with partial-onset seizures on concomitant carbamazepine or valproate.
3/2007Levetiracetam intravenous infusion as an alternative to oral dosing in patients with partial-onset seizures.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Armel Stockis Research Topics

Disease

24Epilepsy (Aura)
02/2022 - 01/2007
19Seizures (Absence Seizure)
01/2020 - 12/2003
5Body Weight (Weight, Body)
01/2019 - 03/2007
4Sleepiness
08/2019 - 05/2006
2Dizziness (Lightheadedness)
01/2018 - 05/2006
1Ataxia (Dyssynergia)
01/2018
1Poisoning
01/2018
1Diplopia (Double Vision)
01/2018
1Partial Epilepsies (Epilepsy, Partial)
11/2014
1Chronic Kidney Failure (Chronic Renal Failure)
11/2014
1Lethargy
09/2010
1Headache (Headaches)
09/2010
1Tachycardia (Tachyarrhythmias)
09/2010
1Contusions
09/2010
1Idiopathic Generalized Epilepsy
07/2009
1Asthma (Bronchial Asthma)
01/2005
1Hypersensitivity (Allergy)
01/2005

Drug/Important Bio-Agent (IBA)

20brivaracetamIBA
02/2022 - 06/2007
14Levetiracetam (Keppra)FDA LinkGeneric
08/2015 - 12/2003
10LigandsIBA
06/2018 - 07/2008
9Anticonvulsants (Antiepileptic Drugs)IBA
01/2020 - 12/2003
9Proteins (Proteins, Gene)FDA Link
06/2018 - 07/2008
5Carbamazepine (Tegretol)FDA LinkGeneric
01/2018 - 04/2007
4Pharmaceutical PreparationsIBA
08/2019 - 03/2007
4LacosamideFDA Link
01/2019 - 11/2014
3Valproic Acid (Depakote)FDA LinkGeneric
12/2016 - 04/2007
2carbamazepine epoxideIBA
12/2019 - 01/2018
1SolutionsIBA
08/2019
1Blood Proteins (Serum Proteins)IBA
11/2014
1CreatinineIBA
11/2014
1Amino AcidsFDA Link
11/2014
1Topiramate (Topamax)FDA LinkGeneric
11/2007
1Lamotrigine (Lamictal)FDA LinkGeneric
11/2007
1Cetirizine (Zyrtec)FDA LinkGeneric
01/2005
1levocetirizineFDA LinkGeneric
01/2005

Therapy/Procedure

5Therapeutics
11/2017 - 04/2007
2Intravenous Administration
02/2022 - 11/2013
1Oral Administration
11/2013
1Intravenous Infusions
03/2007